Clinical trial: Temelimab as a disease-modifying therapy in patients with neuropsychiatric symptoms in Long COVID (or PASC)
Discussion in 'Long Covid news' started by Braganca, Nov 17, 2022.
Discussion in 'Long Covid news' started by Braganca, Nov 17, 2022.